BioCentury
ARTICLE | Company News

Yabao, Salus partner in complex generics

April 22, 2016 3:07 AM UTC

Yabao Pharmaceutical Group Co. Ltd. (Shanghai:600351) partnered with Salus Pharma LLC (Monmouth Junction, N.J.) to develop, manufacture and commercialize complex formulations of generics.

Yabao will hold exclusive ex-U.S. commercialization rights for certain Salus-developed products, while Salus will retain U.S. rights. The partners did not disclose financial details. ...